Frequency of tissue EGFP+ MCs found after treatment with anti–c-kit antibody
. | Mock vector isotype control . | Mock vector anti–c-kit . | F/P-CEL isotype control . | F/P-CEL anti–c-kit . |
---|---|---|---|---|
Spleen | 0.1 ± 0 | 0.035 ± 0.017* | 1.3 ± 0.36 | 0.74 ± 0.38* |
BM | 0.33 ± 0.058 | 0.015 ± 0.024* | 0.98 ± 0.47 | 2.4 ± 1.21 |
Small intestine | 0.36 ± 0.17 | 0.45 ± 0.31 | 30 ± 25.04 | 5.6 ± 4.68* |
. | Mock vector isotype control . | Mock vector anti–c-kit . | F/P-CEL isotype control . | F/P-CEL anti–c-kit . |
---|---|---|---|---|
Spleen | 0.1 ± 0 | 0.035 ± 0.017* | 1.3 ± 0.36 | 0.74 ± 0.38* |
BM | 0.33 ± 0.058 | 0.015 ± 0.024* | 0.98 ± 0.47 | 2.4 ± 1.21 |
Small intestine | 0.36 ± 0.17 | 0.45 ± 0.31 | 30 ± 25.04 | 5.6 ± 4.68* |
Data are shown as mean percentages plus or minus standard deviation.
P < .05 compared with isotype-matched control-treated mice in each group.